Vitrafy Life Sciences

Vitrafy Life Sciences Limited is an Australian life sciences company based in Melbourne, founded in 2017. The company specializes in the research, development, and commercialization of advanced cryopreservation solutions tailored to individual cell lines. Vitrafy focuses on enhancing the quality and consistency of cryopreserved biomaterials for healthcare and biotechnology applications. The company offers smart devices for cryopreservation processes, including smart thawing and packaging devices, along with a proprietary software platform called LifeChain. This platform monitors and tracks the quality standards of cryopreserved biomaterials throughout the supply chain. Vitrafy's specialized solutions cater to cell and gene therapy, as well as aquaculture breeding programs, aiming to improve sustainable farming outcomes. Their technology addresses challenges in cryopreservation, such as reducing cell damage and enhancing post-thaw recovery rates, which is crucial for applications like blood platelet preservation and animal genetics. Vitrafy collaborates with global industry leaders to apply its technology to real-world challenges, including the preservation of CAR T-Cells for cancer treatments and improving fertilization rates in livestock.

• Employees 25
• Founded 2018